rxstat › Classes › Angiotensin Ii Antagonists, Combinations
Angiotensin Ii Antagonists, Combinations: shortage status in Canada
7 of the 9 angiotensin ii antagonists, combinations rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Partial shortageAmlodipine Telmisartan2 of 6 reported products affectedPartial shortageHydrochlorothiazide Candesartan Cilexetil4 of 21 reported products affected · est. return Aug 31, 2026Partial shortageHydrochlorothiazide Irbesartan13 of 35 reported products affected · est. return Dec 4, 2026Partial shortageHydrochlorothiazide Losartan3 of 35 reported products affected · est. return Jul 7, 2026Partial shortageHydrochlorothiazide Valsartan5 of 27 reported products affected · est. return Jul 31, 2026Partial shortageOlmesartan Medoxomil Hydrochlorothiazide6 of 24 reported products affectedPartial shortageTelmisartan Hydrochlorothiazide3 of 23 reported products affectedNo current shortageChlorthalidone Azilsartan MedoxomilDiscontinuedHydrochlorothiazide Eprosartan0 of 1 reported products affected
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.